Articles

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Vol. 103 No. 7 (2018): July, 2018 https://doi.org/10.3324/haematol.2018.189985